

Trending With Impact: Neuromodulation in Alzheimer’s Disease Treatment
May 28, 2022
05:58
Listen to a blog summary of a trending editorial published in Volume 14, Issue 9 of Aging (Aging-US), entitled, "Cognitive training and neuromodulation for Alzheimer treatment."
______________________________________
Many neurodegenerative disorders among elderly populations share common characteristics. In dementias, for example, neurons and glial cells undergo a progressive loss of structure or function in the brain and spinal cord. Alzheimer’s disease (AD) is the most common form of dementia and the main cause of cognitive impairment. Studies have confirmed that cognitive treatments, such as cognitive stimulation, training and rehabilitation, can improve brain function by increasing brain plasticity.
Recently, researcher Fabrizio Vecchio, from IRCCS San Raffaele Roma‘s Brain Connectivity Laboratory, discussed innovative treatment options for Alzheimer’s disease. On April 27, 2022, Dr. Vecchio published his new editorial paper in Volume 14, Issue 9, of Aging (Aging-US), entitled, “Cognitive training and neuromodulation for Alzheimer treatment.”
“Neuromodulation techniques are having a growing consensus as a therapeutic approach of incipient and mild to moderate dementia because of their capability to be modulated both in space, i.e. in different cortical and subcortical areas of the brain, and time.”
Full blog -https://aging-us.org/2022/05/trending-with-impact-neuromodulation-in-alzheimers-disease-treatment/
DOI - https://doi.org/10.18632/aging.204044
Corresponding author - Fabrizio Vecchio - fabrizio.vecchio@uniecampus.it
Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.20404
Keywords - aging, EEG, Small World, cognitive training, rTMS, Alzheimer
About Aging-US
Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.
Please visit our website at http://www.Aging-US.com and connect with us:
SoundCloud - https://soundcloud.com/Aging-Us
Facebook - https://www.facebook.com/AgingUS/
Twitter - https://twitter.com/AgingJrnl
Instagram - https://www.instagram.com/agingjrnl/
YouTube - https://www.youtube.com/agingus
LinkedIn - https://www.linkedin.com/company/aging/
Pinterest - https://www.pinterest.com/AgingUS/
Aging-US is published by Impact Journals, LLC: http://www.ImpactJournals.com
Media Contact
18009220957
MEDIA@IMPACTJOURNALS.COM